Webinar Invitation | Decoding the Complexity of Novel ADC Constructs: Tackling Challenges in Analytical Method Development for CQA MeasurementAccurately characterizing critical quality attributes (CQAs) is becoming increasingly challenging as antibody-drug conjugates (ADCs) evolve toward more complex architectures such as bispecific and dual-payload ADCs.Join Dr. Zhao for practical insights into analytical method development for novel ADCs, with a focus on DAR determination, drug load distribution, free drug, and charge variant analysis. Key Topics Include:• Learn analytical strategies for novel ADC characterization• Explore DAR and drug load distribution analysis• Understand free drug and charge variant analysis• Apply fit-for-purpose analytical approaches for reliable CQA measurement Speaker:Qiang Peng, Ph.D.Director of ADC Conjugation Process Development, AsymBio Register Here: https://us06web.zoom.us/webinar/register/4017702578362/WN_fHGkjt2vRN6psuaojcbRwQ

Webinar Invitation | Accelerating Conjugation Process Development for Next-Generation ADCs: Key Considerations and Platform StrategiesAs the bioconjugate field rapidly evolves beyond traditional ADCs toward next generation ADCs, conjugation process development is becoming increasingly complex. How do you achieve tighter DAR control, improve intermediate stability, strengthen impurity clearance, and ensure scalability — all while accelerating timelines?Join us for an in-depth technical webinar where Dr. Qiang Peng, Director of ADC Conjugation Process Development at AsymBio, will share practical insights and platform strategies to support next-generation ADC development.Key Topics Include: • Understand the current ADC landscape and key trends in next-gen ADCs • Identify the major CMC challenges introduced by next-gen ADC designs • Explain the development strategies for site specific conjugation processes • Develop robust conjugation processes for dual-payload ADCs • Evaluate impurity removal strategy for novel payload linkersSpeaker: Qiang Peng, Ph.D. Director of ADC Conjugation Process Development, AsymBioRegister Here: https://us06web.zoom.us/webinar/register/7417695845826/WN_lz_FcCrZTMqIx_DaYpyMTg

Webinar Invitation | ADC Payload–Linker CMC Strategy from IND to NDA As ADC programs become more complex, payload–linker CMC strategy is playing an increasingly critical role in determining the success of an IND-to-NDA journey. How do you design a robust, regulatory-aligned, and scalable CMC strategy while managing risk, quality, and manufacturability? Join us for an in-depth and practical webinar where Dr. Zheng Wei, Head of Payload-Linker Team at Asymchem CMMD, will share real-world insights on payload–linker CMC development across the entire lifecycle—from clinical development to commercial registration. What you’ll learn: • How payload–linker CMC planning differs between IND and NDA stages • Strategy for route design and regulatory starting material (RSM) selection • Stage-appropriate QC strategy linked to CQAs and impurity control • Practical optimization approaches for purification, crystallization, UF/NF, and lyophilization • How guideline interpretation can be scientifically adjusted under technical constraintsSpeaker:Zheng Wei, Ph.D.Head of Payload-Linker Team, Asymchem CMMDSupporting 70+ INDs and 13 NDAs with extensive experience in high-potency and novel payloads, complex linkers, and GMP manufacturing. Register Here: https://us06web.zoom.us/webinar/register/4017702578362/WN_gvROIdYHSwC73a3B9WaWwQ

Webinar Invitation: Deep Dive into AmigoCHO™ Cell Line Development Platform – Boost Biologics Success!Join AsymBio on Feb. 5th at 10 AM EST | 7 AM PST | 4 PM CET for an exclusive, practical webinar focused on The Performance and Prospect of AmigoCHO™ Cell Line Development (CLD) PlatformSpeaker: Jiawen Xu, Ph.D.Senior Director, Department of Cell Line Development & Center of Biological Technology and Innovation, AsymBioWhat you’ll learn: Understand AsymBio’s capabilities as a partner for antibody and ADC development Learn how the AmigoCHO™ CLD platform is applied in a standardized CLD workflow Identify CLD bottlenecks and toolbox strategies used to facilitate clone screening Take away practical lessons to increase your chances of success in CLDRegister Here:https://us06web.zoom.us/webinar/register/7417695845826/WN_Gryu9CjmR0ytgNdF2_U4tQ

Meet us at Antibody Engineering & Therapeutics in San Diego, Dec. 15-18! Stop by our booth # 120 to meet with our professional team and discuss how our integrated end-to-end approach can help your projects.

AsymBio will be attending the 4th ADC Target Selection Summit at San Diego during Dec. 10-12! Come and visit us to learn more about our integrated ADC CDMO solutions. Our experts will be there to discuss with you on how our integrated end-to-end approach can help your projects.

We will be attending the PEGS Europe at Barcelona during Nov. 5-7! Come and visit our booth # 1022 and our experts will be there to discuss with you on how our integrated end-to-end approach can help your projects.

AsymBio will be exhibiting at 15th World ADC San Diego 2024, November 4-7! Stop by our booth # 402 to meet with our professional team and discuss your project needs. Also, don't miss the drinks reception that hosted by AsymBio on November 5th, we are looking forward to connect with you!

We are pleased to invite you to a webinar on September 24th at 10 AM EST: Navigating Antibody & ADC Advancements: Expert Perspectives and Industry Trends. This event will feature esteemed experts who will discuss the most recent advancements in antibody therapeutics and Antibody-Drug Conjugates (ADCs). Pleasure to have Seah Lim and Janice Reichert with us!Don't miss this opportunity to enhance your understanding of this rapidly evolving field. Register now to secure your spot!Please register through link: https://lnkd.in/gNSMHHBy

AsymBio will be attending the 2nd ADC Process Development Summit at Boston during Sept. 17-19! Come and visit us to learn more about our integrated ADC CDMO solutions. Our experts will be there to discuss with you on how our integrated end-to-end approach can help your projects.